Bolt Biotherapeutics (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- February 05, 2019
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $54,000,000
Company Info
- Founding Year
- 2015
- Founders
- Edgar G. Engleman, MD
- Company Description
- Bolt Biotherapeutics is a biotechnology company that develops a platform for cancer immunotherapy.
- Market
- Cancer therapeutics
- Location
- Redwood City, California, USA
- Coinvestors
- Nan Fung, Novo Holdings, Vivo Capital